| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/19/2002 | US6358952 Combination of benzoquinazoline antifolates and protecting agents |
| 03/19/2002 | US6358945 Compounds useful as anti-inflammatory agents |
| 03/19/2002 | US6358933 Formulation of nucleic acid and acemannan |
| 03/19/2002 | US6358727 Nucleotide sequences coding binding protein for use in treatment and prevention of infections |
| 03/19/2002 | US6358707 Polynucleotide sequences coding polypeptide associated with cellular secretion; for use in treatment of diabetes, stroke, atherosclerosis, restenosis, thrombosis, autoimmune disease, psoriasis, arthritis, crohn's, and inflammatory defects |
| 03/19/2002 | US6358704 M protein |
| 03/19/2002 | US6358509 Administering to animal a polypeptide wherein animal produces antibodies against polypeptide, antibodies being able to specifically bind to human il-4 and are able to inhibit binding of human il-4 to cellular receptors |
| 03/19/2002 | CA2251453C 5-arylalkyl-substituted pyrazolo(4,3-d)pyrimidine-7-ones |
| 03/19/2002 | CA2206804C Trisubstituted thioxanthines |
| 03/19/2002 | CA2151588C Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone |
| 03/18/2002 | CA2319928A1 Apoptosis-mimicking synthetic entities and use thereof in medical treatments |
| 03/15/2002 | CA2357155A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 03/14/2002 | WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | WO2002020769A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | WO2002020767A2 G-csf analog compositions and methods |
| 03/14/2002 | WO2002020766A2 G-csf analog compositions and methods |
| 03/14/2002 | WO2002020762A2 Tnf receptor-like molecules and uses thereof |
| 03/14/2002 | WO2002020743A1 A new polypeptide- human i kappa b kinase 15 and the polynucleotide encoding it |
| 03/14/2002 | WO2002020736A2 Proteases |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 03/14/2002 | WO2002020617A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 03/14/2002 | WO2002020615A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 03/14/2002 | WO2002020608A1 A new polypeptide- human lymph enhanced factor 42 and the polynucleotide encoding it |
| 03/14/2002 | WO2002020607A1 A NEW POLYPEPTIDE-HUMAN BIPHENYL HYDROLASE-RELATED PROTEIN (Bph-rp)16.06 AND THE POLYNUCLEOTIDE ENCODING IT |
| 03/14/2002 | WO2002020606A1 A new polypeptide- human hearing defect-related protein 38.39 and the polynucleotde encoding it |
| 03/14/2002 | WO2002020605A1 A NEW POLYPEPTIDE-HUMAN CELL CYCLIN-E BINDING PROTEIN 1(Ceb1)113-70.07 AND THE POLYNUCLEOTIDE ENCODING IT |
| 03/14/2002 | WO2002020604A1 A new polypeptide- human double-stranded rna binding protein 11 and the polynucleotide encoding it |
| 03/14/2002 | WO2002020603A1 A new polypeptide- human tropomodulin 25.08 and the polynucleotide encoding it |
| 03/14/2002 | WO2002020600A1 A new polypeptide- human zinc finger protein 10.45 and the polynucleotide encoding it |
| 03/14/2002 | WO2002020599A1 A new polypeptide- human transcription regulation factor zfm1 isomer 19.47 and the polynucleotide encoding it |
| 03/14/2002 | WO2002020569A2 Mammalian genes; related reagents and methods |
| 03/14/2002 | WO2002020560A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | WO2002020512A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 03/14/2002 | WO2002020495A2 Inhibitors of glycogen synthase kinase 3 |
| 03/14/2002 | WO2002020489A2 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 03/14/2002 | WO2002020485A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/14/2002 | WO2002020484A1 Chemical compounds |
| 03/14/2002 | WO2002020465A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/14/2002 | WO2002020092A1 Use of serum response factor (srf) modulator for treating srf related diseases |
| 03/14/2002 | WO2002020053A1 Hla binding peptides and their uses |
| 03/14/2002 | WO2002020047A2 Chlamydial peptides and their mimics in demyelinating disease |
| 03/14/2002 | WO2002020045A2 Vaccine against microbial pathogens |
| 03/14/2002 | WO2002020042A1 A method for inducing immunity comprising phagocytic particles and atp receptors |
| 03/14/2002 | WO2002020038A2 Method for down-regulating ige |
| 03/14/2002 | WO2002020034A1 'pseudo'-native chemical ligation |
| 03/14/2002 | WO2002020033A1 Polymer-modified synthetic proteins |
| 03/14/2002 | WO2002020021A1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 03/14/2002 | WO2002020018A1 Tablets containing epinastine manufactured by direct compression |
| 03/14/2002 | WO2002020013A2 A method for treating allergies using substituted pyrazoles |
| 03/14/2002 | WO2002020012A2 Method for treating allergies using substituted pyrazoles |
| 03/14/2002 | WO2002020011A2 A method for treating allergies using substituted pyrazoles |
| 03/14/2002 | WO2002020002A2 A method for treating allergies |
| 03/14/2002 | WO2002019996A2 Prevention of acute sinusitis and sinus attack |
| 03/14/2002 | WO2002019994A2 The treatment of inflammatory disorders |
| 03/14/2002 | WO2002019972A2 Stabilized ascorbic acid solutions |
| 03/14/2002 | WO2002019963A2 Synthetic erythropoiesis stimulating proteins |
| 03/14/2002 | WO2001096564A3 Hla-g (hla-g7) isoform and its applications |
| 03/14/2002 | WO2001078655A3 Methods and compositions for heat shock protein mediated immunotherapy of melanoma |
| 03/14/2002 | WO2001077147A3 New bromodomain protein |
| 03/14/2002 | WO2001076644A3 Lipid-based systems for targeting diagnostic agents |
| 03/14/2002 | WO2001076555A3 Lipid-based drug delivery systems for topical application |
| 03/14/2002 | WO2001072290A3 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 03/14/2002 | WO2001070805A3 Soluble mast cell function associated antigen (mafa) pharmaceutical compositions and methods of making and using them |
| 03/14/2002 | WO2001070757A3 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 03/14/2002 | WO2001070734A3 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 03/14/2002 | WO2001070673A3 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 03/14/2002 | WO2001070668B1 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 03/14/2002 | WO2001068129A3 Adjuvant for vaccines |
| 03/14/2002 | WO2001066543A3 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives |
| 03/14/2002 | WO2001066081A3 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 03/14/2002 | WO2001064163A3 An improved herbal composition having antiallergic properties and a process for the preparation thereof |
| 03/14/2002 | WO2001063286A3 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries |
| 03/14/2002 | WO2001057085A3 G-protein coupled receptors |
| 03/14/2002 | WO2001055392A3 Nuclear hormone receptors |
| 03/14/2002 | WO2001055358A3 Phosphodiesterases |
| 03/14/2002 | WO2001055134A3 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vassopressin receptors |
| 03/14/2002 | WO2001055130A3 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 03/14/2002 | WO2001054707A3 Modification of surface proteins by aminopeptidase inhibitors |
| 03/14/2002 | WO2001051512A3 Human and parasite orphan receptor proteins |
| 03/14/2002 | WO2001035993A3 Compositions and methods for stimulating an immune response against infectious agents |
| 03/14/2002 | WO2001032130A3 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 03/14/2002 | WO2001030327A3 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of ischaemic conditions |
| 03/14/2002 | WO2001027267A3 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 03/14/2002 | WO2001002018A3 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 03/14/2002 | WO2000065028A9 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 03/14/2002 | WO2000056899A9 Dsp-2 dual-specificity map kinase phosphatase |
| 03/14/2002 | WO2000053742A9 Polynucleotides and proteins encoded thereby |
| 03/14/2002 | US20020032332 Hypotensive agents, antiallergens, antiasthma, treating bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorder, gastrointestinal motility or cardiovascular disorders |
| 03/14/2002 | US20020032312 Recombinant multispecific molecule comprising an anti-Fc receptor portion and an anti-target portion. |
| 03/14/2002 | US20020032307 Hepadnavirus pre-S protein fragments |
| 03/14/2002 | US20020032229 Novel compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 03/14/2002 | US20020032225 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
| 03/14/2002 | US20020032224 Treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system disorders |
| 03/14/2002 | US20020032221 Treatment of HIV mediated diseases. |
| 03/14/2002 | US20020032217 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 03/14/2002 | US20020032213 Macrolides |
| 03/14/2002 | US20020032212 A tricyclic compound (with oxy and nitrogen atoms in the ring); perticularly useful for treating or preventing psoriasis and other skin diseases |